CTNM
Contineum Therapeutics Inc.
$10.95
-$1.28(-10.43%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$340.56M
Volume
687.88K
52W Range
$3.35 - $16.25
Target Price
$22.67
Latest News for CTNM
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from RBC Capital
TipRanks Auto-Generated Intelligence Newsdesk•3 days ago•Nov 21, 2025
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Contineum Therapeutics, Inc. Class A, with a price targe......
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from RBC Capital
TipRanks Auto-Generated Intelligence Newsdesk•23 days ago•Nov 01, 2025
RBC Capital analyst Brian Abrahams maintained a Buy rating on Contineum Therapeutics, Inc. Class A on October 30 and set a price target of $25.00. ......
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
TipRanks Auto-Generated Newsdesk•24 days ago•Oct 31, 2025
Contineum Therapeutics, Inc. Class A ( ($CTNM) ) has released its Q3 earnings. Here is a breakdown of the information Contineum Therapeutics, Inc. ......
News data is sourced from MarketXLS API and updated regularly.
Showing 3 of 3 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $10.95 | -10.4% | 687.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW